|
Flores-Blanco P., López-Cuenca Á., Januzzi J., Marín F., Sánchez-Martínez M., Quintana-Giner M., Romero-Aniorte A., Valdés M., Manzano-Fernández S. Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non–ST-Segment Elevation Acute Coronary Syndrome. Clinical Cardiology. 1 September 2016. 39:507-515. 10.1002/clc.22556
AÑO: 2016; IF: 2.757
|
27249221
|
García-Honrubia A, Hernández-Romero D, Orenes-Piñero E, Romero-Aniorte AI, Climent V, García M, Garrigos-Gómez N, Moro C, Valdés M, Marín F. Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy. Eur J Clin Invest. 2016 Feb;46(2):123-9. doi: 10.1111/eci.12572. Epub 2015 Dec 23. PubMed PMID: 26608562.
AÑO: 2016; IF: 2.714
|
|
Roldan V, Marín F. Assessment of bleeding risk in acute ill medical patients. An essential part of venous thromboembolism prevention. Thromb Haemost. 2016 Aug 30;116(3):403-4. doi: 10.1160/TH16-07-0512. Epub 2016 Jul 14. PubMed PMID: 27411774.
AÑO: 2016; IF: 5.627
|
|
Lip G.Y.H., Hammerstingl C., Marin F., Cappato R., Meng I.L., Kirsch B., Van Eickels M., Cohen A. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). American Heart Journal. 1 August 2016. 178:126-134. 10.1016/j.ahj.2016.05.007
AÑO: 2016; IF: 4.436
|
|
Esteve-Pastor MA, Roldán V, Valdés M, Lip GY, Marín F. The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation. Expert Rev Cardiovasc Ther. 2016;14(2):177-87. doi: 10.1586/14779072.2016.1116941. Epub 2015 Dec 9. Review. PubMed PMID: 26559964.
AÑO: 2016
|